Kolltan Pharmaceuticals

Biotechnology Office and Laboratory Renovations (New Haven, Connecticut)

Kolltan is a privately held company that began in 2007, developing an antibody drug targeting receptor tyrosine kinases (RTKs). The first project Babbidge Construction managed for Kolltan was an award winning fast-track renovation of commercial office and laboratory space to house this exciting biomedical start-up company. Since then we have continued to perform construction services as the needs of the company has grown. 205 Whitney Avenue, New Haven, Connecticut 203.562.5559 info@babbidge.com